Published in Clin Rheumatol on August 05, 2010
Autoimmunity in Rheumatic Diseases Is Induced by Microbial Infections via Crossreactivity or Molecular Mimicry. Autoimmune Dis (2012) 1.07
Leprosy and rheumatoid arthritis: consequence or association? BMJ Case Rep (2012) 0.88
Circulating anti-cyclic citrullinated peptide antibody in patients with rheumatoid arthritis and chronic obstructive pulmonary disease. Rheumatol Int (2013) 0.80
Antibodies to citrullinated peptides in tuberculosis. Clin Rheumatol (2013) 0.80
Historical observations contributing insights on etiopathogenesis of rheumatoid arthritis and role of rheumatoid factor. J Exp Med (2016) 0.77
Arthritis and benznidazole: more closely related than we thought. Antimicrob Agents Chemother (2014) 0.75
The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum (1988) 111.05
The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum (2000) 8.64
A NEW SERUM FACTOR IN PATIENTS WITH RHEUMATOID ARTHRITIS; THE ANTIPERINUCLEAR FACTOR. Ann Rheum Dis (1964) 4.03
The incidence of rheumatoid arthritis in the United Kingdom: results from the Norfolk Arthritis Register. Br J Rheumatol (1994) 3.82
Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset. Arthritis Res (2000) 3.03
Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients. Arthritis Rheum (2010) 2.27
Citrullination is an inflammation-dependent process. Ann Rheum Dis (2006) 2.25
Diagnostic accuracy of the anti-citrulline antibody assay for rheumatoid arthritis. Clin Chem (2001) 2.01
Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis. Arthritis Rheum (2007) 1.93
Systematic review: accuracy of anti-citrullinated Peptide antibodies for diagnosing rheumatoid arthritis. Ann Intern Med (2010) 1.78
Antibodies against citrullinated vimentin in rheumatoid arthritis: higher sensitivity and extended prognostic value concerning future radiographic progression as compared with antibodies against cyclic citrullinated peptides. Arthritis Rheum (2008) 1.68
Myelin in multiple sclerosis is developmentally immature. J Clin Invest (1994) 1.52
Antibodies against mutated citrullinated vimentin are a better predictor of disease activity at 24 months in early rheumatoid arthritis than antibodies against cyclic citrullinated peptides. J Rheumatol (2008) 1.42
Anticitrulline peptide antibodies (CCP3) in leprosy sera: a negative association. Clin Rheumatol (2007) 1.40
Technical and diagnostic performance of 6 assays for the measurement of citrullinated protein/peptide antibodies in the diagnosis of rheumatoid arthritis. Clin Chem (2007) 1.37
Prediction of radiographic progression in rheumatoid arthritis and the role of antibodies against mutated citrullinated vimentin: results from a 10-year prospective study. Ann Rheum Dis (2009) 1.36
Positive anti-cyclic citrullinated proteins and rheumatoid factor during active lung tuberculosis. Ann Rheum Dis (2005) 1.29
Diagnostic value of antibodies against a modified citrullinated vimentin in rheumatoid arthritis. Arthritis Res Ther (2006) 1.24
Role of anti-cyclic citrullinated peptide antibodies in discriminating patients with rheumatoid arthritis from patients with chronic hepatitis C infection-associated polyarticular involvement. Arthritis Res Ther (2004) 1.18
Antibodies to mutated citrullinated vimentin for diagnosing rheumatoid arthritis in anti-CCP-negative patients and for monitoring infliximab therapy. Arthritis Res Ther (2008) 1.16
Prevalence of rheumatic diseases in Brazil: a study using the COPCORD approach. J Rheumatol (2004) 1.15
Absence of antibodies to cyclic citrullinated peptide in sera of patients with hepatitis C virus infection and cryoglobulinemia. Arthritis Rheum (2004) 1.15
The fate of trichohyalin. Sequential post-translational modifications by peptidyl-arginine deiminase and transglutaminases. J Biol Chem (1997) 1.12
Antibodies to mutated citrullinated vimentin and disease activity score in early arthritis: a cohort study. Arthritis Res Ther (2008) 1.11
[Incidence and characteristics of the antiperinuclear factor in the blood of patients with rheumatoid arthritis and other diseases]. Boll Soc Ital Biol Sper (1966) 1.09
Patients with pulmonary tuberculosis are frequently positive for anti-cyclic citrullinated peptide antibodies, but their sera also react with unmodified arginine-containing peptide. Arthritis Rheum (2008) 1.05
Clinical utility of the anti-CCP assay: experiences with 700 patients. Ann N Y Acad Sci (2005) 1.03
Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis. J Rheumatol (2007) 1.03
Value of anti-mutated citrullinated vimentin antibodies in diagnosing rheumatoid arthritis. Rheumatol Int (2008) 1.03
Antibody against mutated citrullinated vimentin: a new sensitive marker in the diagnosis of rheumatoid arthritis. Rheumatol Int (2009) 1.02
Does anti-mutated citrullinated vimentin have additional value as a serological marker in the diagnostic and prognostic investigation of patients with rheumatoid arthritis? A systematic review. Ann Rheum Dis (2009) 1.02
The anti-cyclic citrullinated peptide response in tuberculosis patients is not citrulline-dependent and sensitive to treatment. Arthritis Res Ther (2010) 1.00
The role of anti-mutated citrullinated vimentin antibodies in the diagnosis of early rheumatoid arthritis. J Rheumatol (2009) 0.98
Antibodies to citrullinated vimentin are a specific and sensitive marker for the diagnosis of rheumatoid arthritis. Clin Rev Allergy Immunol (2008) 0.98
The serological diagnosis of rheumatoid arthritis: antibodies to citrullinated antigens. Dtsch Arztebl Int (2009) 0.95
Serum markers of rheumatoid arthritis in visceral leishmaniasis: rheumatoid factor and anti-cyclic citrullinated peptide antibody. J Autoimmun (2007) 0.94
Diagnostic utility of anti-cyclic citrullinated peptide and anti-modified citrullinated vimentin antibodies in rheumatoid arthritis. Protein Pept Lett (2008) 0.94
Usefulness of anti-CCP antibodies in patients with hepatitis C virus infection with or without arthritis, rheumatoid factor, or cryoglobulinemia. Clin Rheumatol (2007) 0.92
Diagnostic value of anti-MCV antibodies in differentiating early inflammatory arthritis. Ann Rheum Dis (2009) 0.90
A comparison of the frequency of antibodies to cyclic citrullinated peptides using a third generation anti-CCP assay (CCP3) in systemic sclerosis, primary biliary cirrhosis and rheumatoid arthritis. Clin Rheumatol (2007) 0.90
Changing pattern of deiminated proteins in developing human epidermis. J Invest Dermatol (2003) 0.89
Comparative performance analysis of 4 different anti-citrullinated protein assays in the diagnosis of rheumatoid arthritis. J Rheumatol (2009) 0.88
Anti-cyclic citrullinated peptide antibodies in hepatitis C virus associated rheumatological manifestations and Sjogren's syndrome. Ann Rheum Dis (2006) 0.88
Anti-cyclic citrullinated peptide antibodies as a discriminating marker between rheumatoid arthritis and chronic hepatitis C-related polyarthropathy. Rheumatol Int (2009) 0.88
Anti-citrullinated protein antibodies in rheumatoid arthritis: as good as it gets? Clin Rev Allergy Immunol (2008) 0.88
Meta-analysis: diagnostic value of serum anti-mutated citrullinated vimentin antibodies in patients with rheumatoid arthritis. Rheumatol Int (2010) 0.87
Determination of anti-cyclic citrullinated peptide antibodies in the sera of patients with liver diseases. Clin Exp Rheumatol (2008) 0.87
Absence of cyclic citrullinated peptide antibody in nonarthritic patients with chronic hepatitis C infection. J Rheumatol (2005) 0.87
Absence of antibody to cyclic citrullinated peptide in sera of non-arthritic patients with chronic hepatitis B virus infection. Clin Rheumatol (2006) 0.83
The positivity of rheumatoid factor and anti-cyclic citrullinated peptide antibody in nonarthritic patients with chronic hepatitis C infection. Rheumatol Int (2009) 0.83
Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in leprosy patients with articular involvement. Braz J Med Biol Res (2008) 0.82
Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection. J Rheumatol (2009) 0.78
The anti-mutated citrullinated vimentin response classifies patients with rheumatoid arthritis into broad and narrow responders. J Rheumatol (2009) 0.77
Anti-cyclic citrullinated peptide antibodies in patients affected by HCV-related arthritis. J Biol Regul Homeost Agents (2008) 0.77
Clinical significance of anti-cyclic citrullinated peptide antibodies in Egyptian patients with chronic hepatitis C virus genotype IV infection. Clin Chem Lab Med (2009) 0.76
Diagnostic utility of anti-cyclic citrullinated peptide antibodies for rheumatoid arthritis in patients with active lung tuberculosis. Clin Rheumatol (2008) 0.76
Anti-cyclic citrulline peptide antibody in non-tuberculous mycobacteria sera: a negative association. Clin Rheumatol (2010) 0.75
[Demonstration of an antiperinuclear factor in patients with rheumatic diseases, liver diseases and lung tuberculosis using fluorescence technic]. Z Gesamte Inn Med (1972) 0.75
Kikuchi-Fujimoto's disease associated with systemic lupus erythematosus: case report and review of the literature. Clin Rheumatol (2004) 1.14
Chloroquine ototoxicity. Clin Rheumatol (2007) 1.01
Antiphospholipid antibodies in HIV-positive patients. Clin Rheumatol (2007) 0.90
Magnetic resonance imaging of Jaccoud's arthropathy in systemic lupus erythematosus. Joint Bone Spine (2010) 0.87
Prevalence and classification of headache in patients with systemic lupus erythematosus. Clin Rheumatol (2006) 0.85
Imaging of Jaccoud's arthropathy in systemic lupus erythematosus: not only hands but also knees and feet. Rheumatol Int (2011) 0.76
Lupoid sclerosis: what is the role of antiphospholipid antibodies? J Clin Rheumatol (2007) 0.76
Fasciitis-panniculitis syndrome simulating deep venous thrombosis. Eur J Intern Med (2007) 0.75
Thyroid acropachy. J Clin Rheumatol (2007) 0.75